Second-line treatments for the management of advanced renal cell carcinoma: systematic review and meta-analysis

Author： Larkin James   Paine Abby   Tumur Indra   Cappelleri Joseph C   Healey Paul J   Foley Grace   Mitchell Stephen   Kroes Michel   Chen Connie  

Publisher： Informa Healthcare

ISSN： 1465-6566

Source： Expert Opinion on Pharmacotherapy, Vol.14, Iss.1, 2013-01, pp. : 27-39

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

The UK NICE has not recommended everolimus [Afinitor] as second-line treatment for advanced renal cell carcinoma.

By  

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 627, 2011-01 ,pp. : 11-11

Adis International

Access to resources Recommend Favorite

Comparative Risk for Harms of Second-Generation Antidepressants: A Systematic Review and Meta-Analysis

By Gartlehner Gerald   Thieda Patricia  

Drug Safety, Vol. 31, Iss. 10, 2008-01 ,pp. : 851-865

Adis International

Access to resources Recommend Favorite

The Role of Antidepressants in the Management of Fibromyalgia Syndrome: A Systematic Review and Meta-Analysis

By Häuser Winfried   Wolfe Frederick   Tölle Thomas  

CNS Drugs, Vol. 26, Iss. 4, 2012-04 ,pp. : 297-307

Adis International

Access to resources Recommend Favorite

Inhibition of the VEGF/VEGFR Pathway Improves Survival in Advanced Kidney Cancer: A Systematic Review and Meta-Analysis

By  

Current Drug Targets, Vol. 16, Iss. 2, 2015-01 ,pp. : 164-170

Bentham Science Publishers

Access to resources Recommend Favorite

Metabolic and Neurological Complications of Second-Generation Antipsychotic Use in Children: A Systematic Review and Meta-Analysis of Randomized Controlled Trials

By Pringsheim Tamara  

Drug Safety, Vol. 34, Iss. 8, 2011-08 ,pp. : 651-668

Adis International

Access to resources Recommend Favorite